Deleterious BRCA1/2 mutations in an urban population of Black women. - 2015

Information on the prevalence of deleterious BRCA1 and BRCA2 (BRCA1/2) mutations in clinic-based populations of Black women is limited. In order to address this gap, we performed a retrospective study to determine the prevalence of deleterious BRCA1/2 mutations, predictors of having a mutation, and acceptance of risk-reducing surgeries in Black women. In an urban unselected clinic-based population, we evaluated 211 self-identified Black women who underwent genetic counseling for hereditary breast-ovarian cancer syndrome. BRCA1/2 mutations were identified in 13.4% of the participants who received genetic testing. Younger age at diagnosis, higher BRCAPRO score, significant family history, and diagnosis of triple-negative breast cancer were associated with identification of a BRCA1/2 mutation. Of the affected patients found to have a deleterious mutation, almost half underwent prophylactic measures. In our study population, 1 in 7 Black women who underwent genetic testing harbored a deleterious BRCA1/2 mutation independent of age at diagnosis or family history.


English

0167-6806


*African Continental Ancestry Group/ge [Genetics]
*Genes, BRCA1
*Genes, BRCA2
*Mutation
*Population Surveillance
*Urban Population
Adult
Aged
District of Columbia/eh [Ethnology]
District of Columbia/ep [Epidemiology]
Female
Genetic Counseling
Genetic Testing
Hereditary Breast and Ovarian Cancer Syndrome/ep [Epidemiology]
Hereditary Breast and Ovarian Cancer Syndrome/ge [Genetics]
Humans
Middle Aged
Prognosis
Registries
Retrospective Studies
Triple Negative Breast Neoplasms/ep [Epidemiology]
Triple Negative Breast Neoplasms/ge [Genetics]
Young Adult


Washington Cancer Institute


Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't